FierceBiotech

FDA clears AI software for spotting prostate cancer in MRI scans

A small, Nebraska-based company has received FDA clearance for artificial intelligence-driven software that helps pick out the signs of prostate cancer in MRI scans. Bot Image’s ProstatID program was ...

MRI contrast agent design continues path to safer, more effective diagnostics

Scientists at the University of Birmingham have developed a new class of MRI contrast agents, improving their stability to ...
Medscape

No Benefit to Adding Spectroscopy to MRI for Localization of Peripheral Zone Prostate Cancer

November 30, 2006 (Chicago) -- Magnetic resonance spectroscopic imaging (MRSI) shows no advantages over magnetic resonance imaging (MRI) alone for localization of peripheral zone prostate cancer in ...
The New England Journal of Medicine

Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only

Screening for prostate cancer is burdened by a high rate of overdiagnosis. The most appropriate algorithm for population-based screening is unknown. We invited 37,887 men who were 50 to 60 years of ...
FierceBiotech

FDA clears Philips AI for making CT-like images from head and neck MRI scans

Philips has received clearance from the FDA for its artificial-intelligence-powered MRI platform geared toward head and neck cancers. Dubbed MRCAT, for MR for Calculating ATtenuation, the application ...